Survival of prostate cancer patients in central and northern Denmark, 1998–2009

Figures & data

Figure 1 The age distribution of men diagnosed with prostate cancer in the period 1998–2009 in two of the five Danish regions.

Figure 2 Overall survival in Danish prostate cancer patients diagnosed in the period 1998–2009 in two of the five Danish regions.

Table 1 The 1-, 3-, and 5-year overall survival and MRR adjusted for age in the four time periods

	Year of diagnosis
	1998–2000	2001–2003	2004–2006	2007–2009
Number of cancer patients	1684	2120	2962	3781
Median age (years)	74	74	72	70
1 year
Survival	80% (78%–82%)	82% (80%–84%)	89% (88%–90%)	90% (89%–91%)
Relative mortality	1(reference)	0.88 (0.76–1.02)	0.51 (0.44–0.60)	0.44 (0.38–0.51)
Adjusted MRRa	1(reference)	0.89 (0.77–1.03)	0.56 (0.48–0.66)	0.54 (0.46–0.63)
3 year
Survival	47% (44%–49%)	59% (56%–61%)	70% (69%–72%)	73% (72%–75%)b
Relative mortality	1(reference)	0.73 (0.66–0.80)	0.47 (0.43–0.52)	0.41 (0.37–0.45)b
Adjusted MRRa	1(reference)	0.73 (0.67–0.80)	0.50 (0.46–0.55)	0.46 (0.42–0.51)b
5 year
Survival	34% (31%–36%)	45% (43%–47%)	57% (55%–59%)b	60% (58%–62%)b
Relative mortality	1(reference)	0.75 (0.69–0.81)	0.50 (0.46–0.54)b	0.45 (0.41–0.48)b
Adjusted MRRa	1(reference)	0.75 (0.69–0.81)	0.53 (0.49–0.57)b	0.50 (0.46–0.54)b

Notes: Long-term survival is predicted values.

a Adjusted for age;

b predicted values.

Abbreviation: MRR, mortality rate ratio.

Table 2 The 1-, 3-, and 5-year survival in the four time periods according to three different age groups

Age (years)	Year of diagnosis
	1998–2000	2001–2003	2004–2006	2007–2009
15–69
N umber of cancer patients	565	739	1197	1832
1-year survival	88% (86%–91%)	90% (87%–92%)	95% (94%–96%)	97% (96%–97%)
3-year survival	60% (56%–64%)	72% (68%–75%)	84% (81%–86%)	86% (85%–88%)a
5-year survival	48% (43%–52%)	63% (59%–66%)	75% (72%–77%)a	78% (75%–80%)a
70–79
N umber of cancer patients	690	855	1178	1354
1-year survival	81% (77%–83%)	84% (81%–86%)	89% (87%–91%)	90% (89%–92%)
3-year survival	48% (44%–52%)	60% (57%–64%)	69% (66%–71%)	71% (68%–73%)a
5-year survival	34% (30%–37%)	45% (42%–48%)	56% (53%–58%)a	57% (54%–60%)a
80+
N umber of cancer patients	429	526	587	595
1-year survival	67% (62%–71%)	68% (64%–72%)	76% (72%–79%)	72% (68%–76%)
3-year survival	27% (23%–31%)	37% (33%–41%)	45% (41%–49%)	44% (40%–48%)a
5-year survival	15% (12%–19%)	18% (15%–22%)	25% (22%–29%)a	24% (21%–28%)a

Note: Long-term survival is predicted values.

a Predicted values.